Feedback plc
Statement re share price
Cambridge, 27 September 2019: Feedback plc (AIM: FDBK, "Feedback" or the "Company") notes the movement in the share price today. The Company notes the announcement earlier today by IQ-AI Ltd that Imaging Biometrics, IQ-AI's Milwaukee based subsidiary, today received notification that the FDA has cleared StoneChecker Software for marketing in the USA ("the FDA Clearance"). Stonechecker is a licensee of Feedback's TexRAD® software and the Directors believe that the Stonechecker Software uses TexRAD®. However, the Company is currently not able to evaluate what level of income, if any, will accrue as a result of the FDA Clearance. In addition, the FDA Clearance does not confer FDA clearance for TexRAD® and the Directors are now evaluating the implications of this as part of their ongoing strategic review.
A further announcement will be made in due course.
Enquiries:
|
|
Feedback plc Tom Oakley, CEO Lindsay Melvin, CFO
|
+44 (0)1954 718072 |
Allenby Capital Limited (Nominated Adviser) David Worlidge / Asha Chotai
|
+44 (0)20 3328 5656 |
Peterhouse Capital Limited (Joint Broker) Lucy Williams / Duncan Vasey
|
+44 (0)20 7469 0936 |
Stanford Capital Partners Limited (Joint Broker) Patrick Claridge / John Howes
Instinctif Partners Rozi Morris/ Deborah Bell/ Phillip Marriage |
+44 20 3815 8880
+44 (0)20 7457 2020 |
Notes to editors
About Feedback plc
Feedback plc (AIM: FDBK) is a specialist medical imaging technology company providing innovative software and systems, through its fully-owned trading subsidiary, Feedback Medical Limited. Its products advance the work of radiologists, clinicians and medical researchers by improving workflows and giving unique insights into diseases, particularly cancer. Feedback Medical works with customers globally from headquarters in the internationally renowned scientific hub of Cambridge, UK. Its proprietary technologies are TexRAD®, the quantitative texture analysis tool and Cadran, a picture archiving communication system (PACS). The Company has recently announced the launch of its new messaging and image transfer product Bleepa™. For more information, see www.fbk.com